日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Lactobacillus gasseri 30S ribosomal protein S17 (rpsQ) CSB-YP312945LAU
CSB-EP312945LAU
CSB-BP312945LAU
CSB-MP312945LAU
CSB-EP312945LAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus gasseri 50S ribosomal protein L22 (rplV) CSB-YP312946LAU
CSB-EP312946LAU
CSB-BP312946LAU
CSB-MP312946LAU
CSB-EP312946LAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus gasseri 50S ribosomal protein L23 (rplW) CSB-YP312947LAU
CSB-EP312947LAU
CSB-BP312947LAU
CSB-MP312947LAU
CSB-EP312947LAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus gasseri DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP312948LAU
CSB-EP312948LAU
CSB-BP312948LAU
CSB-MP312948LAU
CSB-EP312948LAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Canine coronavirus Nucleoprotein (N) CSB-YP312949CCP
CSB-BP312949CCP
CSB-MP312949CCP
CSB-EP312949CCP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Transposon Ty1-ML1 Gag-Pol polyprotein (TY1B-ML1), partial CSB-YP312950SVG
CSB-EP312950SVG
CSB-BP312950SVG
CSB-MP312950SVG
CSB-EP312950SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Petunia hybrida 60S ribosomal protein L16, mitochondrial (RPL16) CSB-YP312951EUD
CSB-EP312951EUD
CSB-BP312951EUD
CSB-MP312951EUD
CSB-EP312951EUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant rRNA adenine N-6-methyltransferase (ermJ) CSB-YP312952BQE
CSB-EP312952BQE
CSB-BP312952BQE
CSB-MP312952BQE
CSB-EP312952BQE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Ribonuclease H (RNH1) CSB-YP312954SVG
CSB-EP312954SVG
CSB-BP312954SVG
CSB-MP312954SVG
CSB-EP312954SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Nuclear fusion protein KAR5 (KAR5), partial CSB-YP312955SVG1
CSB-EP312955SVG1
CSB-BP312955SVG1
CSB-MP312955SVG1
CSB-EP312955SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactococcus phage mv4 Major capsid protein (g34) CSB-YP312956LBK
CSB-EP312956LBK
CSB-BP312956LBK
CSB-MP312956LBK
CSB-EP312956LBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactococcus phage LL-H Minor structural protein Gp20 (g20) CSB-YP312957LBI
CSB-EP312957LBI
CSB-BP312957LBI
CSB-MP312957LBI
CSB-EP312957LBI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Glutamate decarboxylase (GAD1), partial CSB-YP312958SVG
CSB-EP312958SVG
CSB-BP312958SVG
CSB-MP312958SVG
CSB-EP312958SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus gasseri 30S ribosomal protein S6 (rpsF) CSB-YP312959LAU
CSB-EP312959LAU
CSB-BP312959LAU
CSB-MP312959LAU
CSB-EP312959LAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus Glucosamine-6-phosphate deaminase (nagB) CSB-YP312960LAR
CSB-EP312960LAR
CSB-BP312960LAR
CSB-MP312960LAR
CSB-EP312960LAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus delbrueckii subsp. bulgaricus UDP-N-acetylmuramyl-tripeptide synthetase (murE), partial CSB-YP312961LAR
CSB-EP312961LAR
CSB-BP312961LAR
CSB-MP312961LAR
CSB-EP312961LAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Dipicolinate synthase subunit B (dpaB) CSB-YP312962BRJ
CSB-EP312962BRJ
CSB-BP312962BRJ
CSB-MP312962BRJ
CSB-EP312962BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana 31 kDa ribonucleoprotein, chloroplastic (RBP31) CSB-YP312963DOA
CSB-EP312963DOA
CSB-BP312963DOA
CSB-MP312963DOA
CSB-EP312963DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YMR254C (YMR254C), partial CSB-YP312964SVG1
CSB-EP312964SVG1
CSB-BP312964SVG1
CSB-MP312964SVG1
CSB-EP312964SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Outer surface protein A (ospA) CSB-YP312965BIO
CSB-EP312965BIO
CSB-BP312965BIO
CSB-MP312965BIO
CSB-EP312965BIO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×